Interview 6 Sep 2017
The CAR-T Race is Far from Over: This CEO is Exploring a New Avenue
…launched in 2007, it wasn’t a CAR-T product but naturally occurring T cells targeting viral antigens for the treatment of infections. The company then used this technology to target cancers…